| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to peptide vaccines against cancer. There are presented epitope peptides derived from the TTK gene that elicit CTL development, pharmaceutical compositions containing as active ingredients the above peptides or polynucleotides coding the peptides. n EFFECT: there are presented antigen-presenting cells and recovered CTLs which target the above peptides and methods for inducing the antigen-presenting cells or CTLs. n 18 cl, 4 dwg, 1 ex |